Close Menu

NEW YORK ─ Biocartis on Thursday reported 68 percent growth in year-over-year commercial cartridge volume for the first quarter of 2020.

Mechelen, Belgium-based Biocartis also said that in Q1, it saw slower than expected installed base expansion due to the COVID-19 pandemic, with the main impact occurring in Southern European, US, and rest of the world markets.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.